What Medical Contraindications And Skin Conditions Must Aesthetic Practitioners Screen For Prior To Operating Microneedling And Superficial Skin Rejuvenation Equipment? Essential Safety Checklist

Screening must happen before every microneedling or superficial skin-rejuvenation treatment. Practitioners should identify conditions that increase bleeding, infection, inflammation, pigment change, scarring, or delayed wound healing. Key exclusions include active skin disease or infection in the treatment area, blood-thinning therapy, uncontrolled diabetes, impaired immunity or wound healing, pregnancy or breastfeeding, and relevant medication or device-specific risks.

Microneedling and superficial rejuvenation create controlled injury or energy exposure. Treatment should proceed only when the client’s medical history, medications, skin condition, and chosen device indicate that healing and complication risks are acceptably controlled.

What the Screening Must Establish

The client’s medical history

Ask about diabetes, autoimmune disease, cancer, immune deficiency, connective-tissue disease, abnormal scarring, previous radiation therapy, and any known wound-healing disorder.

Uncontrolled diabetes is a significant contraindication because it can impair healing and increase the risk of infection. Clients with complex medical conditions may require physician clearance or exclusion under local clinical protocols.

Current medications and recent treatments

Review all prescription medicines, over-the-counter products, supplements, and recent cosmetic or medical procedures.

Particular attention is required for:

Anticoagulants and antiplatelet medicines, which can increase bleeding and bruising.
Aspirin and NSAIDs, where clinically relevant, because they may impair clotting or increase bruising.
Fish-oil supplements, which may also be relevant to bleeding-risk assessment.
Topical retinoids, which should generally be discontinued for approximately 3 to 7 days before treatment according to the treatment protocol.
Oral isotretinoin, where microneedling or resurfacing should be deferred according to current clinical guidance and the device or procedure protocol. The supplied references specify a six-month interval after discontinuation.
Photosensitizing medicines, particularly when using light- or energy-based equipment.

Medication changes should never be instructed without appropriate medical oversight. The practitioner should document the medicine, assess the risk, and refer or defer when necessary.

Pregnancy and breastfeeding status

Pregnancy and breastfeeding are commonly treated as contraindications or reasons to defer cosmetic procedures, particularly where safety data are limited or topical medicines, anesthetics, light, radiofrequency, ultrasound, or other energy modalities may be involved.

The practitioner should confirm current pregnancy or lactation status before treatment rather than relying on assumptions.

Skin Conditions That Require Exclusion

Active acne and localized inflammation

Do not needle or mechanically treat active grade III or IV acne, particularly papulopustular or inflamed lesions.

Passing equipment over inflamed lesions can spread contamination, intensify inflammation, trigger breakouts, and cause additional mechanical trauma.

Rosacea and other inflammatory disorders

Defer treatment over papulopustular rosacea, inflamed rosacea, or other acutely inflamed skin conditions.

The treatment area should be stable and free from active inflammation. A history of rosacea alone is not equivalent to active disease, but it should prompt careful assessment and conservative treatment planning.

Herpes simplex and other infections

Do not treat areas affected by:

Active herpes simplex, including cold sores.
Bacterial or other active skin infections.
Open wounds or compromised skin barriers.
Burns, rashes, or acutely inflamed lesions.

Treatment should be postponed until the condition has resolved and the skin barrier has recovered.

Raised lesions and suspicious growths

Avoid microneedling or superficial resurfacing over raised skin lesions, malignant lesions, or any lesion that has not been clinically assessed.

Aesthetic equipment should not be used to traumatize, flatten, remove, or disguise a lesion. Suspicious or changing lesions require medical evaluation before cosmetic treatment.

Keloids and abnormal scarring

A personal history of keloid formation or abnormal scarring increases concern when a procedure deliberately creates skin injury.

This is particularly important for microneedling and more aggressive resurfacing. The practitioner should follow the device protocol and obtain medical advice where required.

Koebner-prone conditions

Conditions such as psoriasis, vitiligo, and lichen planus may worsen after skin trauma through a Koebner response.

These conditions are generally risk factors or relative contraindications rather than automatic exclusions in every circumstance. Treatment should be avoided over active disease and considered only with appropriate clinical judgment.

Additional Safety Checks

Recent sun exposure and tanning

Sunburned or recently exposed skin should not be treated. Clients should avoid significant sun exposure beforehand; the supplied protocol specifies avoiding sun exposure and sunburn for at least 48 hours before treatment.

Tanned or melanin-rich skin requires particular caution with light-based equipment because epidermal melanin absorbs more energy and can increase the risk of burns and dyschromia. Fitzpatrick skin types IV through VI may require specialist assessment, lower settings, or pigment-prevention protocols depending on the device.

Pigment-change risk

Clients with darker skin types or a history of post-inflammatory hyperpigmentation should be assessed for pigment risk before any procedure that causes inflammation or thermal exposure.

Pre-treatment pigment-lightening agents may be used in some protocols, but only when clinically appropriate and compatible with the device and treatment plan.

Implanted electrical devices

For radiofrequency, electrical, ultrasound, or other energy-based equipment, check for implanted electrical devices, including pacemakers and defibrillators.

This contraindication is device-specific and must be verified against the manufacturer’s instructions. It should not automatically be applied to every microneedling device.

Neuromuscular disorders

Screen for neuromuscular disorders such as myasthenia gravis or Eaton-Lambert syndrome when the treatment involves electrical stimulation, neuromuscular effects, or medicines that may affect neuromuscular transmission.

This consideration is more relevant to certain energy-based or electrical modalities than to standard mechanical microneedling. The equipment’s instructions for use should determine whether medical clearance is required.

Epilepsy, cancer, and other device-specific risks

Some energy-based procedures list epilepsy, active cancer, malignant lesions, or photosensitizing medication as contraindications or precautions.

These risks must be assessed in relation to the specific modality. A contraindication for IPL, laser, radiofrequency, HIFU, or electrical equipment should not be assumed to apply identically to mechanical microneedling.

Understanding the Trade-offs

Contraindications are device-specific

“Superficial skin rejuvenation equipment” covers different mechanisms, including mechanical needling, dermaplaning, chemical exfoliation, IPL, laser, radiofrequency, and ultrasound.

Their contraindications overlap but are not interchangeable. The practitioner must combine the client assessment with the manufacturer’s instructions, professional standards, and local regulations.

Combining procedures increases treatment intensity

Removing superficial skin layers before applying a chemical peel or another treatment can significantly increase penetration and treatment intensity.

Sequential procedures should therefore be planned conservatively. A combination that is acceptable when performed separately may create excessive irritation or tissue injury when performed in the same session.

A relative contraindication is not permission to proceed automatically

A relative contraindication means that treatment may require modification, specialist input, or documented medical clearance. It does not mean the risk can be ignored or managed solely by lowering the device setting.

Screening should include the treatment area

A client may be medically suitable overall but unsuitable for treatment on a particular area.

The practitioner should inspect the skin immediately before treatment for inflammation, infection, wounds, lesions, sunburn, active acne, and any change from the initial consultation.

Making the Right Choice for Your Goal

A safe decision depends on both the client’s risk profile and the exact equipment or combination being used.

If your primary focus is preventing bleeding and delayed healing: Defer clients with active anticoagulant risk, uncontrolled diabetes, significant immune or wound-healing disorders, or recent procedures until the risk has been medically assessed.
If your primary focus is preventing infection and inflammatory complications: Do not treat active acne, rosacea, herpes simplex, bacterial infection, open wounds, burns, rashes, or other inflamed skin in the target area.
If your primary focus is preventing scarring or pigment changes: Screen for keloids, abnormal scars, Koebner-prone disorders, recent tanning, darker skin types, and prior post-inflammatory hyperpigmentation.
If your primary focus is operating energy-based equipment safely: Check pregnancy or breastfeeding, implanted electrical devices, photosensitizing medicines, recent isotretinoin use, epilepsy, cancer, and every contraindication listed for that specific device.
If your primary focus is combining superficial treatments: Reassess the cumulative intensity because exfoliation can increase the penetration and effect of subsequent chemical or energy-based treatments.

A rigorous, device-specific screening process protects the client, supports predictable healing, and keeps aesthetic treatment within defensible clinical safety limits.

Summary Table:

Contraindication Category	Examples	Risk	Action
Active Skin Conditions	Acne, rosacea, herpes, wounds	Infection, inflammation	Defer until resolved
Medications	Anticoagulants, NSAIDs, isotretinoin	Bleeding, impaired healing	Assess risk, defer if needed
Medical History	Uncontrolled diabetes, immune deficiency	Poor healing, infection	Require medical clearance
Pregnancy/Breastfeeding	Any	Unknown risks	Defer treatment
Skin Type/History	Fitzpatrick IV-VI, keloid scarring	Pigment changes, scarring	Consider pigment protocols, avoid if high risk
Device-Specific	Implanted devices (with energy-based)	Interference	Check manufacturer's instructions

Ensure the safety and efficacy of your aesthetic treatments with BELIS's professional-grade devices. Our advanced laser, IPL, and microneedling systems are designed for clinics and premium salons, backed by comprehensive training and support. Contact us today to learn how BELIS can help you deliver superior results while prioritizing client safety.